Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Can J Anaesth ; 70(11): 1839-1844, 2023 11.
Article in English | MEDLINE | ID: mdl-37789220

ABSTRACT

PURPOSE: Timely diagnosis of perioperative stroke is challenging, and therapeutic interventions are infrequently offered. The cortical hand syndrome is a rare stroke presentation that results from infarction of the precentral gyrus leading to variable neurologic deficits mimicking peripheral nerve injuries, with no prior reports in the perioperative setting. To raise awareness of this complication among anesthesiologists, we present a case of cortical hand syndrome in a surgical patient initially suspected to have a peripheral neuropathy. CLINICAL FEATURES: A 68-yr-old male with multiple stroke risk factors underwent a nephroureterectomy under general anesthesia and thoracic epidural analgesia for urothelial carcinoma. The patient noted right-hand numbness and weakness to digits 3-5 immediately after surgery and notified his bedside nurse the following day. His symptoms were initially presumed to be a peripheral neuropathy secondary to surgical positioning. Computed tomography of the head the following day revealed an acute cortical infarct in the precentral gyrus consistent with cortical hand stroke syndrome. Subsequent neurologic consultation revealed additional subtle right-sided weakness. Further workup revealed moderate (60-80%) stenosis of the left carotid artery and he underwent a successful carotid endarterectomy one week later. His symptoms had mostly resolved six weeks later. CONCLUSION: Cortical hand stroke syndrome is a rare presentation of perioperative stroke that may be misdiagnosed as a peripheral neuropathy. Our case presentation highlights that perioperative stroke should be considered for patients presenting with neurologic deficits of the hand, particularly those with deficits in multiple peripheral nerve territories and stroke risk factors.


RéSUMé: OBJECTIF: Le diagnostic rapide de l'accident vasculaire cérébral (AVC) périopératoire est difficile, et les interventions thérapeutiques sont rarement proposées. Le syndrome de la main corticale est une présentation rare de l'AVC qui résulte d'un infarctus du gyrus précentral entraînant des déficits neurologiques variables imitant les lésions nerveuses périphériques, sans avoir été préalablement rapporté dans le cadre périopératoire. Afin de sensibiliser les anesthésiologistes à cette complication, nous présentons un cas de syndrome de la main corticale chez un patient chirurgical chez lequel une neuropathie périphérique était initialement suspectée. CARACTéRISTIQUES CLINIQUES: Un homme de 68 ans présentant de multiples facteurs de risque d'AVC a subi une néphro-urétérectomie sous anesthésie générale et une analgésie péridurale thoracique pour un carcinome urothélial. Le patient a remarqué un engourdissement et une faiblesse de la main droite du majeur à l'auriculaire immédiatement après la chirurgie et a avisé le personnel infirmier à son chevet le lendemain. On a d'abord présumé que ses symptômes indiquaient une neuropathie périphérique secondaire au positionnement chirurgical. La tomodensitométrie de la tête réalisée le lendemain a révélé un infarctus cortical aigu dans le gyrus précentral, compatible avec un syndrome d'AVC de la main corticale. Une consultation neurologique ultérieure a révélé une faiblesse subtile supplémentaire du côté droit. Un examen plus approfondi a révélé une sténose modérée (60 à 80 %) de l'artère carotide gauche et le patient a bénéficié d' une endartériectomie carotidienne réussie une semaine plus tard. Ses symptômes avaient pour la plupart disparu six semaines plus tard. CONCLUSION: Le syndrome de l'AVC de la main corticale est une présentation rare d'AVC périopératoire qui peut être diagnostiqué à tort comme une neuropathie périphérique. Notre présentation de cas souligne que l'AVC périopératoire devrait être envisagé chez les patient·es présentant des déficits neurologiques de la main, en particulier chez les personnes présentant des déficits dans plusieurs territoires nerveux périphériques et des facteurs de risque d'AVC.


Subject(s)
Carcinoma, Transitional Cell , Endarterectomy, Carotid , Peripheral Nervous System Diseases , Stroke , Urinary Bladder Neoplasms , Humans , Male , Carcinoma, Transitional Cell/complications , Urinary Bladder Neoplasms/complications , Stroke/diagnosis , Stroke/etiology , Upper Extremity , Peripheral Nervous System Diseases/diagnosis , Risk Factors , Endarterectomy, Carotid/adverse effects
2.
Br J Anaesth ; 131(5): 925-936, 2023 11.
Article in English | MEDLINE | ID: mdl-37716887

ABSTRACT

BACKGROUND: Poor pain control during the postoperative period has negative implications for recovery, and is a critical risk factor for development of persistent postsurgical pain. The aim of this scoping review is to identify gaps in healthcare delivery that patients undergoing inpatient noncardiac surgeries experience in pain management while recovering at home. METHODS: Searches were conducted by a medical librarian in PubMed, MEDLINE, EMBASE, EBSCO CINAHL, Web of Science, and Cochrane Database of Systematic Reviews for articles published between 2016 and 2022. Inclusion criteria were adults (≥18 yr), English language, inpatient noncardiac surgery, and included at least one gap in care for acute and/or persistent pain management after surgery within the first 3 months of recovery at home. Two reviewers independently screened articles for inclusion and extracted data. Quotations from each article related to gaps in care were synthesised using thematic analysis. RESULTS: There were 4794 results from databases and grey literature, of which 38 articles met inclusion criteria. From these, 23 gaps were extracted, encompassing all six domains of healthcare delivery (capacity, organisational structure, finances, patients, care processes and infrastructure, and culture). Identified gaps were synthesised into five overarching themes: education (22 studies), provision of continuity of care (21 studies), individualised management (10 studies), support for specific populations (11 studies), and research and knowledge translation (10 studies). CONCLUSIONS: This scoping review identified health delivery gaps during a critical period in postoperative pain management. These gaps represent potential targets for quality improvement and future research to improve perioperative care and longer-term patient-centred outcomes. SCOPING REVIEW PROTOCOL: Open Science Framework (https://osf.io/cq5m6/).


Subject(s)
Pain Management , Patient Discharge , Adult , Humans , Inpatients , Systematic Reviews as Topic , Delivery of Health Care
3.
Transplantation ; 107(6): 1398-1405, 2023 06 01.
Article in English | MEDLINE | ID: mdl-36482750

ABSTRACT

BACKGROUND: With >700 transplant surgeries performed each year, Toronto General Hospital (TGH) is currently one of the largest adult transplant centers in North America. There is a lack of literature regarding both the identification and management of chronic postsurgical pain (CPSP) after organ transplantation. Since 2014, the TGH Transitional Pain Service (TPS) has helped manage patients who developed CPSP after solid organ transplantation (SOT), including heart, lung, liver, and renal transplants. METHODS: In this retrospective cohort study, we describe the association between opioid consumption, psychological characteristics of pain, and demographic characteristics of 140 SOT patients who participated in the multidisciplinary treatment at the TGH TPS, incorporating psychology and physiotherapy as key parts of our multimodal pain management regimen. RESULTS: Treatment by the multidisciplinary TPS team was associated with significant improvement in pain severity and a reduction in opioid consumption. CONCLUSIONS: Given the risk of CPSP after SOT, robust follow-up and management by a multidisciplinary team should be considered to prevent CPSP, help guide opioid weaning, and provide psychological support to these patients to improve their recovery trajectory and quality of life postoperatively.


Subject(s)
Opioid-Related Disorders , Organ Transplantation , Adult , Humans , Analgesics, Opioid/therapeutic use , Hospitals, General , Retrospective Studies , Quality of Life , Pain, Postoperative/prevention & control , Opioid-Related Disorders/prevention & control
5.
Can J Anaesth ; 62(11): 1161-8, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26159436

ABSTRACT

PURPOSE: The use of ultrasound (US) for radial arterial catheterization has been reported to result in faster insertion times with fewer complications when compared with traditional direct palpation (DP). We sought to determine if this applies to expert operators and tested the hypothesis that, among cardiac anesthesiologists, US-guided insertion similarly results in faster insertion times as well as fewer re-directs, attempts, and complications. METHODS: Following Research Ethics Board Approval, we conducted a randomized clinical trial in 125 patients scheduled for cardiac surgery at a single tertiary/quaternary care centre. Patients were randomized to either US- or DP-guided radial artery catheterization by attending cardiac anesthesiologists. The primary endpoint was time to catheter placement. Secondary endpoints included the number of attempts and re-directs as well as the failure rate. RESULTS: There were no differences between the DP- (n = 62) vs US-guided (n = 63) groups in median [interquartile range] time to placement (104 [76-212] sec vs 104 [68-270] sec, respectively; P = 0.66), number of re-directs (2 [0-6] vs 3 [1-5], respectively; P = 0.82), or number of attempts (1 [1-2] vs 1 [1-2], respectively; P = 0.08). The first-attempt success rate was 56.4% in the DP group and 71.4 % in the US group (P = 0.10). Failure rate and hematoma rate in the DP group were 21.0% and 22.6%, respectively, compared with 12.7% and 11.1% in the US group (P = 0.24 and 0.10, respectively). CONCLUSIONS: Among experienced cardiac anesthesiologists, the use of US to facilitate radial arterial catheterization did not affect insertion times, the number of re-directs, or the number of attempts when compared with DP. Ultrasound use had no significant effects on the rates of success on first attempt, failure, or hematoma formation. This trial was registered at www.clinicaltrials.gov : NCT02118441.


Subject(s)
Anesthesiology/methods , Cardiac Surgical Procedures , Catheterization, Peripheral/methods , Palpation , Radial Artery/diagnostic imaging , Ultrasonography, Interventional , Aged , Canada , Female , Humans , Male , Physicians
6.
Expert Rev Anticancer Ther ; 12(3): 345-57, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22369326

ABSTRACT

Differentiated thyroid carcinoma (DTC) accounts for more than 90% of new thyroid cancer diagnoses, and includes papillary, follicular and Hürthle cell carcinoma. The prognosis for the vast majority of individuals diagnosed with DTC is excellent, with current treatment that includes surgery, radioactive iodine ablation and postoperative thyroid-stimulating hormone suppression. Unfortunately, the small proportion of individuals who develop radioactive iodine-resistant recurrent disease have few treatment options, and the vast majority will eventually die from their disease. Recently, several novel targets for anticancer agents have been identified and offer new hope for thyroid cancer patients diagnosed with progressive disease. In addition to targeting genes commonly altered in thyroid cancer, which include mutations in BRAF, RAS and RET, proangiogenic growth factor receptors and the sodium-iodide symporter have also been targeted. Several clinical trials evaluating tyrosine kinase and angiogenesis inhibitors for treatment of individuals diagnosed with metastatic or treatment-refractory DTC are currently underway. The objective of this review is to evaluate recent clinical trials that have studied novel targeted drugs for treatment of DTC.


Subject(s)
Carcinoma , Molecular Targeted Therapy/methods , Neovascularization, Pathologic , Targeted Gene Repair/methods , Thyroid Gland , Thyroid Neoplasms , Angiogenesis Inhibitors/pharmacology , Carcinoma/genetics , Carcinoma/therapy , Cell Dedifferentiation/drug effects , Cell Dedifferentiation/genetics , Clinical Trials, Phase II as Topic , Disease Progression , Disease Resistance , Genes, ras , Humans , Mutation , Neovascularization, Pathologic/drug therapy , Neovascularization, Pathologic/etiology , Neovascularization, Pathologic/genetics , Protein-Tyrosine Kinases/antagonists & inhibitors , Proto-Oncogene Proteins B-raf/genetics , Proto-Oncogene Proteins c-ret/genetics , Therapies, Investigational , Thyroid Gland/blood supply , Thyroid Gland/pathology , Thyroid Neoplasms/complications , Thyroid Neoplasms/genetics , Thyroid Neoplasms/physiopathology , Thyroid Neoplasms/therapy
7.
Reproduction ; 143(3): 347-57, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22157319

ABSTRACT

Tubulobulbar complexes (TBCs) are elaborate cytoskeleton-related structures that are formed in association with intercellular junctions in the seminiferous epithelium. They consist of a cylindrical double-membrane core composed of the plasma membranes of the two attached cells, cuffed by a dendritic network of actin filaments. TBCs are proposed to be subcellular machines that internalize intercellular junctions during the extensive junction remodeling that occurs during spermatogenesis. At the apical sites of attachment between Sertoli cells and spermatids, junction disassembly is part of the sperm release mechanism. In this study, we used immunological probes to explore junction internalization and recycling at apical TBCs in the rat seminiferous epithelium. We demonstrate that ß1-integrin and nectin 2 were concentrated at the ends of TBCs and for the first time show that the early endosome marker RAB5A was also distinctly localized at the ends of TBCs that appear to be the 'bulbar' regions of the complexes. Significantly, we also demonstrate that the 'long-loop' recycling endosome marker RAB11A was co-distributed with nectin 2 at junctions with early spermatids deeper in the epithelium. Our results are consistent with the hypothesis that TBCs associated with late spermatids internalize adhesion junctions and also indicate that some of the internalized junction proteins may be recycled to form junctions with the next generation of spermatids.


Subject(s)
Adherens Junctions/metabolism , Cell Adhesion Molecules/metabolism , Endocytosis/physiology , Endosomes/metabolism , Seminiferous Epithelium/metabolism , Animals , Biomarkers/metabolism , Fluorescent Antibody Technique , Integrin beta Chains/metabolism , Male , Nectins , Protein Binding , Protein Transport , Rats , Rats, Sprague-Dawley , Seminiferous Epithelium/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...